2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide

C41H40F3N9O6S3 — CID 73294896

IUPAC2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide
SMILESCN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2cccc(N3CCc4cccc(C(=O)Nc5cn6ccncc6n5)c4C3)n2)cc1S(=O)(=O)C(F)(F)F
InChIInChI=1S/C41H40F3N9O6S3/c1-51(2)19-17-28(26-60-29-9-4-3-5-10-29)46-33-15-14-30(22-35(33)61(56,57)41(42,43)44)62(58,59)50-40(55)34-12-7-13-37(47-34)52-20-16-27-8-6-11-31(32(27)24-52)39(54)49-36-25-53-21-18-45-23-38(53)48-36/h3-15,18,21-23,25,28,46H,16-17,19-20,24,26H2,1-2H3,(H,49,54)(H,50,55)/t28-/m1/s1
InChIKeyOVZDUUCAKFYQSE-MUUNZHRXSA-N
MW908.02 g/mol
LogP5.88
Rot. Bonds15

About 2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide

2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide (PubChem CID 73294896) has the molecular formula C41H40F3N9O6S3 and a molecular weight of 908.02 g/mol. Its IUPAC name is 2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide.

Molecular Properties

Compound Name2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide
PubChem CID73294896
Molecular FormulaC41H40F3N9O6S3
Molecular Weight908.02 g/mol
Exact Mass907.22
IUPAC Name2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide
SMILESCN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2cccc(N3CCc4cccc(C(=O)Nc5cn6ccncc6n5)c4C3)n2)cc1S(=O)(=O)C(F)(F)F
InChIInChI=1S/C41H40F3N9O6S3/c1-51(2)19-17-28(26-60-29-9-4-3-5-10-29)46-33-15-14-30(22-35(33)61(56,57)41(42,43)44)62(58,59)50-40(55)34-12-7-13-37(47-34)52-20-16-27-8-6-11-31(32(27)24-52)39(54)49-36-25-53-21-18-45-23-38(53)48-36/h3-15,18,21-23,25,28,46H,16-17,19-20,24,26H2,1-2H3,(H,49,54)(H,50,55)/t28-/m1/s1
InChIKeyOVZDUUCAKFYQSE-MUUNZHRXSA-N
XLogP5.88
TPSA188.07 Ų
H-Bond Donors3
H-Bond Acceptors14
Rotatable Bonds15
Heavy Atoms62
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500908.02
LogP ≤ 55.88
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1014

Analyze 2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide?
The IUPAC name of 2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide (CID 73294896) is 2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide.
What is the SMILES notation for 2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide?
The canonical SMILES for 2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide is CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2cccc(N3CCc4cccc(C(=O)Nc5cn6ccncc6n5)c4C3)n2)cc1S(=O)(=O)C(F)(F)F.
What is the InChIKey of 2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide?
The InChIKey is OVZDUUCAKFYQSE-MUUNZHRXSA-N. The full InChI is InChI=1S/C41H40F3N9O6S3/c1-51(2)19-17-28(26-60-29-9-4-3-5-10-29)46-33-15-14-30(22-35(33)61(56,57)41(42,43)44)62(58,59)50-40(55)34-12-7-13-37(47-34)52-20-16-27-8-6-11-31(32(27)24-52)39(54)49-36-25-53-21-18-45-23-38(53)48-36/h3-15,18,21-23,25,28,46H,16-17,19-20,24,26H2,1-2H3,(H,49,54)(H,50,55)/t28-/m1/s1.
What are the key properties of 2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide?
2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide has a molecular weight of 908.02 g/mol, XLogP of 5.88, 15 rotatable bonds, 3 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[6-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylcarbamoyl]-2-pyridinyl]-N-imidazo[1,2-a]pyrazin-2-yl-3,4-dihydro-1H-isoquinoline-8-carboxamide is sourced from PubChem (CID 73294896), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).